Part identity
00670-0674-30
Loratadine Tablets
Novartis Pharmaceuticals Corporation
Avg quote: 14 minFulfilled from Anaheim, CAAS9120:2025 · ISO 9001 · FAA AC 00-56BC of C, lot & date code with every line
Part description
Loratadine Tablets
ASAP supports this specific part for replacement, spare-pool replenishment, retrofit, and urgent maintenance requirements. Quote requests can include alternate MPN, condition preferences, certification needs, and plant-specific receiving instructions so procurement gets a clear sourcing response before purchase.
Specifications
Certifications & documentation
- UL Recognized
- CE
- C of C available on request
NP
Manufacturer
Novartis Pharmaceuticals Corporation
Authorized-distributor or qualified-aftermarket source. Parts shipped from this manufacturer include full traceability paperwork and counterfeit-mitigation per SAE AS6081.
View manufacturer profile →NSN Information for Part Number 00670-0674-30 with NSN 6505-01-377-1461, 6505013771461
Characteristics Data of NSN 6505-01-377-1461, 6505013771461
| MRC | Criteria | Characteristic |
|---|---|---|
| MRC | Decoded Requirement | Clear Text Reply |
| AKJA | Active Medicament Medicinal Strength | 10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT |
| CXCY | Part Name Assigned By Controlling Agency | LORATADINE TABLETS 10MG 30S PG |
| CBBL | Features Provided | UNIT DOSE |
| CRLK | Primary Container Content Quantity | 10.000 TABLETS |
| THPE | Therapeutic Equivalent | SCHERING |
| CSCW | Total Primary Container Quantity | 3 |
| CQCT | Primary Container Type | CARD |
